Baird Maintains Neutral on Dentsply Sirona, Raises Price Target to $14
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Baird analyst Jeffrey Johnson maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raises the price target from $12 to $14.
Baird analyst Jeffrey Johnson maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raises the price target from $12 to $14.